ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ophthalmology Therapeutics Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-7R13463
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Ophthalmology Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Ophthalmology Therapeutics Market Research Report 2025

Code: QYRE-Auto-7R13463
Report
May 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Aerie Pharmaceuticals
Bayer
F.Hoffmann-La Roche
Novartis
Otsuka Holdings
Santen Pharmaceutical
Teva Pharmaceutical Industries
Regeneron Pharmaceuticals
Pfizer Inc

Ophthalmology Therapeutics Market Size

The global market for Ophthalmology Therapeutics was valued at US$ 157 million in the year 2024 and is projected to reach a revised size of US$ 217 million by 2031, growing at a CAGR of 4.8% during the forecast period.

Ophthalmology Therapeutics Market

Ophthalmology Therapeutics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ophthalmology Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmology Therapeutics.
The Ophthalmology Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ophthalmology Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ophthalmology Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Ophthalmology Therapeutics Market Report

Report Metric Details
Report Name Ophthalmology Therapeutics Market
Accounted market size in year US$ 157 million
Forecasted market size in 2031 US$ 217 million
CAGR 4.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie, Aerie Pharmaceuticals, Bayer, F. Hoffmann-La Roche, Novartis AG, Otsuka Holdings, Pfizer, Regeneron Pharmaceuticals, Santen Pharmaceutical, Teva Pharmaceutical Industries
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Ophthalmology Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Ophthalmology Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Ophthalmology Therapeutics Market growing?

Ans: The Ophthalmology Therapeutics Market witnessing a CAGR of 4.8% during the forecast period 2025-2031.

What is the Ophthalmology Therapeutics Market size in 2031?

Ans: The Ophthalmology Therapeutics Market size in 2031 will be US$ 217 million.

Who are the main players in the Ophthalmology Therapeutics Market report?

Ans: The main players in the Ophthalmology Therapeutics Market are AbbVie, Aerie Pharmaceuticals, Bayer, F. Hoffmann-La Roche, Novartis AG, Otsuka Holdings, Pfizer, Regeneron Pharmaceuticals, Santen Pharmaceutical, Teva Pharmaceutical Industries

What are the Application segmentation covered in the Ophthalmology Therapeutics Market report?

Ans: The Applications covered in the Ophthalmology Therapeutics Market report are Glaucoma, Dry Eye Syndrome, Eye Infection, Other

What are the Type segmentation covered in the Ophthalmology Therapeutics Market report?

Ans: The Types covered in the Ophthalmology Therapeutics Market report are Gels, Eye Solutions, Capsules & Tablets, Ointments

Recommended Reports

Ophthalmic Therapeutics

Glaucoma & Eye Disorders

Retina & Cataract Care

1 Ophthalmology Therapeutics Market Overview
1.1 Product Definition
1.2 Ophthalmology Therapeutics by Type
1.2.1 Global Ophthalmology Therapeutics Market Value Comparison by Type (2024 VS 2031)
1.2.2 Gels
1.2.3 Eye Solutions
1.2.4 Capsules & Tablets
1.2.5 Ointments
1.3 Ophthalmology Therapeutics by Application
1.3.1 Global Ophthalmology Therapeutics Market Value by Application (2024 VS 2031)
1.3.2 Glaucoma
1.3.3 Dry Eye Syndrome
1.3.4 Eye Infection
1.3.5 Other
1.4 Global Ophthalmology Therapeutics Market Size Estimates and Forecasts
1.4.1 Global Ophthalmology Therapeutics Revenue 2020-2031
1.4.2 Global Ophthalmology Therapeutics Sales 2020-2031
1.4.3 Global Ophthalmology Therapeutics Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Ophthalmology Therapeutics Market Competition by Manufacturers
2.1 Global Ophthalmology Therapeutics Sales Market Share by Manufacturers (2020-2025)
2.2 Global Ophthalmology Therapeutics Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Ophthalmology Therapeutics Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Ophthalmology Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ophthalmology Therapeutics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ophthalmology Therapeutics, Product Type & Application
2.7 Global Key Manufacturers of Ophthalmology Therapeutics, Date of Enter into This Industry
2.8 Global Ophthalmology Therapeutics Market Competitive Situation and Trends
2.8.1 Global Ophthalmology Therapeutics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Ophthalmology Therapeutics Players Market Share by Revenue
2.8.3 Global Ophthalmology Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Ophthalmology Therapeutics Market Scenario by Region
3.1 Global Ophthalmology Therapeutics Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Ophthalmology Therapeutics Sales by Region: 2020-2031
3.2.1 Global Ophthalmology Therapeutics Sales by Region: 2020-2025
3.2.2 Global Ophthalmology Therapeutics Sales by Region: 2026-2031
3.3 Global Ophthalmology Therapeutics Revenue by Region: 2020-2031
3.3.1 Global Ophthalmology Therapeutics Revenue by Region: 2020-2025
3.3.2 Global Ophthalmology Therapeutics Revenue by Region: 2026-2031
3.4 North America Ophthalmology Therapeutics Market Facts & Figures by Country
3.4.1 North America Ophthalmology Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Ophthalmology Therapeutics Sales by Country (2020-2031)
3.4.3 North America Ophthalmology Therapeutics Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ophthalmology Therapeutics Market Facts & Figures by Country
3.5.1 Europe Ophthalmology Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Ophthalmology Therapeutics Sales by Country (2020-2031)
3.5.3 Europe Ophthalmology Therapeutics Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ophthalmology Therapeutics Market Facts & Figures by Region
3.6.1 Asia Pacific Ophthalmology Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Ophthalmology Therapeutics Sales by Region (2020-2031)
3.6.3 Asia Pacific Ophthalmology Therapeutics Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Ophthalmology Therapeutics Market Facts & Figures by Country
3.7.1 Latin America Ophthalmology Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Ophthalmology Therapeutics Sales by Country (2020-2031)
3.7.3 Latin America Ophthalmology Therapeutics Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ophthalmology Therapeutics Market Facts & Figures by Country
3.8.1 Middle East and Africa Ophthalmology Therapeutics Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Ophthalmology Therapeutics Sales by Country (2020-2031)
3.8.3 Middle East and Africa Ophthalmology Therapeutics Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ophthalmology Therapeutics Sales by Type (2020-2031)
4.1.1 Global Ophthalmology Therapeutics Sales by Type (2020-2025)
4.1.2 Global Ophthalmology Therapeutics Sales by Type (2026-2031)
4.1.3 Global Ophthalmology Therapeutics Sales Market Share by Type (2020-2031)
4.2 Global Ophthalmology Therapeutics Revenue by Type (2020-2031)
4.2.1 Global Ophthalmology Therapeutics Revenue by Type (2020-2025)
4.2.2 Global Ophthalmology Therapeutics Revenue by Type (2026-2031)
4.2.3 Global Ophthalmology Therapeutics Revenue Market Share by Type (2020-2031)
4.3 Global Ophthalmology Therapeutics Price by Type (2020-2031)
5 Segment by Application
5.1 Global Ophthalmology Therapeutics Sales by Application (2020-2031)
5.1.1 Global Ophthalmology Therapeutics Sales by Application (2020-2025)
5.1.2 Global Ophthalmology Therapeutics Sales by Application (2026-2031)
5.1.3 Global Ophthalmology Therapeutics Sales Market Share by Application (2020-2031)
5.2 Global Ophthalmology Therapeutics Revenue by Application (2020-2031)
5.2.1 Global Ophthalmology Therapeutics Revenue by Application (2020-2025)
5.2.2 Global Ophthalmology Therapeutics Revenue by Application (2026-2031)
5.2.3 Global Ophthalmology Therapeutics Revenue Market Share by Application (2020-2031)
5.3 Global Ophthalmology Therapeutics Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Company Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie Ophthalmology Therapeutics Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Aerie Pharmaceuticals
6.2.1 Aerie Pharmaceuticals Company Information
6.2.2 Aerie Pharmaceuticals Description and Business Overview
6.2.3 Aerie Pharmaceuticals Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Aerie Pharmaceuticals Ophthalmology Therapeutics Product Portfolio
6.2.5 Aerie Pharmaceuticals Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer Ophthalmology Therapeutics Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 F. Hoffmann-La Roche
6.4.1 F. Hoffmann-La Roche Company Information
6.4.2 F. Hoffmann-La Roche Description and Business Overview
6.4.3 F. Hoffmann-La Roche Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 F. Hoffmann-La Roche Ophthalmology Therapeutics Product Portfolio
6.4.5 F. Hoffmann-La Roche Recent Developments/Updates
6.5 Novartis AG
6.5.1 Novartis AG Company Information
6.5.2 Novartis AG Description and Business Overview
6.5.3 Novartis AG Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis AG Ophthalmology Therapeutics Product Portfolio
6.5.5 Novartis AG Recent Developments/Updates
6.6 Otsuka Holdings
6.6.1 Otsuka Holdings Company Information
6.6.2 Otsuka Holdings Description and Business Overview
6.6.3 Otsuka Holdings Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Otsuka Holdings Ophthalmology Therapeutics Product Portfolio
6.6.5 Otsuka Holdings Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Pfizer Ophthalmology Therapeutics Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Regeneron Pharmaceuticals
6.8.1 Regeneron Pharmaceuticals Company Information
6.8.2 Regeneron Pharmaceuticals Description and Business Overview
6.8.3 Regeneron Pharmaceuticals Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Regeneron Pharmaceuticals Ophthalmology Therapeutics Product Portfolio
6.8.5 Regeneron Pharmaceuticals Recent Developments/Updates
6.9 Santen Pharmaceutical
6.9.1 Santen Pharmaceutical Company Information
6.9.2 Santen Pharmaceutical Description and Business Overview
6.9.3 Santen Pharmaceutical Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Santen Pharmaceutical Ophthalmology Therapeutics Product Portfolio
6.9.5 Santen Pharmaceutical Recent Developments/Updates
6.10 Teva Pharmaceutical Industries
6.10.1 Teva Pharmaceutical Industries Company Information
6.10.2 Teva Pharmaceutical Industries Description and Business Overview
6.10.3 Teva Pharmaceutical Industries Ophthalmology Therapeutics Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Teva Pharmaceutical Industries Ophthalmology Therapeutics Product Portfolio
6.10.5 Teva Pharmaceutical Industries Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ophthalmology Therapeutics Industry Chain Analysis
7.2 Ophthalmology Therapeutics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ophthalmology Therapeutics Production Mode & Process Analysis
7.4 Ophthalmology Therapeutics Sales and Marketing
7.4.1 Ophthalmology Therapeutics Sales Channels
7.4.2 Ophthalmology Therapeutics Distributors
7.5 Ophthalmology Therapeutics Customer Analysis
8 Ophthalmology Therapeutics Market Dynamics
8.1 Ophthalmology Therapeutics Industry Trends
8.2 Ophthalmology Therapeutics Market Drivers
8.3 Ophthalmology Therapeutics Market Challenges
8.4 Ophthalmology Therapeutics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AbbVie
Aerie Pharmaceuticals
Bayer
F.Hoffmann-La Roche
Novartis
Otsuka Holdings
Santen Pharmaceutical
Teva Pharmaceutical Industries
Regeneron Pharmaceuticals
Pfizer Inc
List of Tables
 Table 1. Global Ophthalmology Therapeutics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Ophthalmology Therapeutics Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Ophthalmology Therapeutics Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Ophthalmology Therapeutics Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Ophthalmology Therapeutics Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Ophthalmology Therapeutics Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Ophthalmology Therapeutics Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Ophthalmology Therapeutics Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Ophthalmology Therapeutics, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Ophthalmology Therapeutics, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Ophthalmology Therapeutics, Product Type & Application
 Table 12. Global Key Manufacturers of Ophthalmology Therapeutics, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Ophthalmology Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmology Therapeutics as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Ophthalmology Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Ophthalmology Therapeutics Sales by Region (2020-2025) & (K Units)
 Table 18. Global Ophthalmology Therapeutics Sales Market Share by Region (2020-2025)
 Table 19. Global Ophthalmology Therapeutics Sales by Region (2026-2031) & (K Units)
 Table 20. Global Ophthalmology Therapeutics Sales Market Share by Region (2026-2031)
 Table 21. Global Ophthalmology Therapeutics Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Ophthalmology Therapeutics Revenue Market Share by Region (2020-2025)
 Table 23. Global Ophthalmology Therapeutics Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Ophthalmology Therapeutics Revenue Market Share by Region (2026-2031)
 Table 25. North America Ophthalmology Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Ophthalmology Therapeutics Sales by Country (2020-2025) & (K Units)
 Table 27. North America Ophthalmology Therapeutics Sales by Country (2026-2031) & (K Units)
 Table 28. North America Ophthalmology Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Ophthalmology Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Ophthalmology Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Ophthalmology Therapeutics Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Ophthalmology Therapeutics Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Ophthalmology Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Ophthalmology Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Ophthalmology Therapeutics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Ophthalmology Therapeutics Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Ophthalmology Therapeutics Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Ophthalmology Therapeutics Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Ophthalmology Therapeutics Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Ophthalmology Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Ophthalmology Therapeutics Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Ophthalmology Therapeutics Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Ophthalmology Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Ophthalmology Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Ophthalmology Therapeutics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Ophthalmology Therapeutics Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Ophthalmology Therapeutics Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Ophthalmology Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Ophthalmology Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Ophthalmology Therapeutics Sales (K Units) by Type (2020-2025)
 Table 51. Global Ophthalmology Therapeutics Sales (K Units) by Type (2026-2031)
 Table 52. Global Ophthalmology Therapeutics Sales Market Share by Type (2020-2025)
 Table 53. Global Ophthalmology Therapeutics Sales Market Share by Type (2026-2031)
 Table 54. Global Ophthalmology Therapeutics Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Ophthalmology Therapeutics Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Ophthalmology Therapeutics Revenue Market Share by Type (2020-2025)
 Table 57. Global Ophthalmology Therapeutics Revenue Market Share by Type (2026-2031)
 Table 58. Global Ophthalmology Therapeutics Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Ophthalmology Therapeutics Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Ophthalmology Therapeutics Sales (K Units) by Application (2020-2025)
 Table 61. Global Ophthalmology Therapeutics Sales (K Units) by Application (2026-2031)
 Table 62. Global Ophthalmology Therapeutics Sales Market Share by Application (2020-2025)
 Table 63. Global Ophthalmology Therapeutics Sales Market Share by Application (2026-2031)
 Table 64. Global Ophthalmology Therapeutics Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Ophthalmology Therapeutics Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Ophthalmology Therapeutics Revenue Market Share by Application (2020-2025)
 Table 67. Global Ophthalmology Therapeutics Revenue Market Share by Application (2026-2031)
 Table 68. Global Ophthalmology Therapeutics Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Ophthalmology Therapeutics Price (US$/Unit) by Application (2026-2031)
 Table 70. AbbVie Company Information
 Table 71. AbbVie Description and Business Overview
 Table 72. AbbVie Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AbbVie Ophthalmology Therapeutics Product
 Table 74. AbbVie Recent Developments/Updates
 Table 75. Aerie Pharmaceuticals Company Information
 Table 76. Aerie Pharmaceuticals Description and Business Overview
 Table 77. Aerie Pharmaceuticals Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Aerie Pharmaceuticals Ophthalmology Therapeutics Product
 Table 79. Aerie Pharmaceuticals Recent Developments/Updates
 Table 80. Bayer Company Information
 Table 81. Bayer Description and Business Overview
 Table 82. Bayer Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Bayer Ophthalmology Therapeutics Product
 Table 84. Bayer Recent Developments/Updates
 Table 85. F. Hoffmann-La Roche Company Information
 Table 86. F. Hoffmann-La Roche Description and Business Overview
 Table 87. F. Hoffmann-La Roche Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. F. Hoffmann-La Roche Ophthalmology Therapeutics Product
 Table 89. F. Hoffmann-La Roche Recent Developments/Updates
 Table 90. Novartis AG Company Information
 Table 91. Novartis AG Description and Business Overview
 Table 92. Novartis AG Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Novartis AG Ophthalmology Therapeutics Product
 Table 94. Novartis AG Recent Developments/Updates
 Table 95. Otsuka Holdings Company Information
 Table 96. Otsuka Holdings Description and Business Overview
 Table 97. Otsuka Holdings Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Otsuka Holdings Ophthalmology Therapeutics Product
 Table 99. Otsuka Holdings Recent Developments/Updates
 Table 100. Pfizer Company Information
 Table 101. Pfizer Description and Business Overview
 Table 102. Pfizer Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Pfizer Ophthalmology Therapeutics Product
 Table 104. Pfizer Recent Developments/Updates
 Table 105. Regeneron Pharmaceuticals Company Information
 Table 106. Regeneron Pharmaceuticals Description and Business Overview
 Table 107. Regeneron Pharmaceuticals Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Regeneron Pharmaceuticals Ophthalmology Therapeutics Product
 Table 109. Regeneron Pharmaceuticals Recent Developments/Updates
 Table 110. Santen Pharmaceutical Company Information
 Table 111. Santen Pharmaceutical Description and Business Overview
 Table 112. Santen Pharmaceutical Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Santen Pharmaceutical Ophthalmology Therapeutics Product
 Table 114. Santen Pharmaceutical Recent Developments/Updates
 Table 115. Teva Pharmaceutical Industries Company Information
 Table 116. Teva Pharmaceutical Industries Description and Business Overview
 Table 117. Teva Pharmaceutical Industries Ophthalmology Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Teva Pharmaceutical Industries Ophthalmology Therapeutics Product
 Table 119. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Ophthalmology Therapeutics Distributors List
 Table 123. Ophthalmology Therapeutics Customers List
 Table 124. Ophthalmology Therapeutics Market Trends
 Table 125. Ophthalmology Therapeutics Market Drivers
 Table 126. Ophthalmology Therapeutics Market Challenges
 Table 127. Ophthalmology Therapeutics Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Ophthalmology Therapeutics
 Figure 2. Global Ophthalmology Therapeutics Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Ophthalmology Therapeutics Market Share by Type: 2024 & 2031
 Figure 4. Gels Product Picture
 Figure 5. Eye Solutions Product Picture
 Figure 6. Capsules & Tablets Product Picture
 Figure 7. Ointments Product Picture
 Figure 8. Global Ophthalmology Therapeutics Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Ophthalmology Therapeutics Market Share by Application: 2024 & 2031
 Figure 10. Glaucoma
 Figure 11. Dry Eye Syndrome
 Figure 12. Eye Infection
 Figure 13. Other
 Figure 14. Global Ophthalmology Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Ophthalmology Therapeutics Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Ophthalmology Therapeutics Sales (2020-2031) & (K Units)
 Figure 17. Global Ophthalmology Therapeutics Average Price (US$/Unit) & (2020-2031)
 Figure 18. Ophthalmology Therapeutics Report Years Considered
 Figure 19. Ophthalmology Therapeutics Sales Share by Manufacturers in 2024
 Figure 20. Global Ophthalmology Therapeutics Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Ophthalmology Therapeutics Players: Market Share by Revenue in Ophthalmology Therapeutics in 2024
 Figure 22. Ophthalmology Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Ophthalmology Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Ophthalmology Therapeutics Sales Market Share by Country (2020-2031)
 Figure 25. North America Ophthalmology Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 26. United States Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Ophthalmology Therapeutics Sales Market Share by Country (2020-2031)
 Figure 29. Europe Ophthalmology Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Ophthalmology Therapeutics Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Ophthalmology Therapeutics Revenue Market Share by Region (2020-2031)
 Figure 37. China Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Ophthalmology Therapeutics Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Ophthalmology Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Ophthalmology Therapeutics Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Ophthalmology Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Ophthalmology Therapeutics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Ophthalmology Therapeutics by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Ophthalmology Therapeutics by Type (2020-2031)
 Figure 56. Global Ophthalmology Therapeutics Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Ophthalmology Therapeutics by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Ophthalmology Therapeutics by Application (2020-2031)
 Figure 59. Global Ophthalmology Therapeutics Price (US$/Unit) by Application (2020-2031)
 Figure 60. Ophthalmology Therapeutics Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Ophthalmic Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmic Pharmaceutical Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmic Drug Delivery Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmic Disease Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ophthalmology AI assisted Diagnosis Software Market Research Report 2024
Global Ophthalmic Anti Infective Drugs Market Research Report 2025
Global Ocular Drug Delivery Market Research Report 2025
Global Pharma Ophthalmic Market Research Report 2025
Global Eye Drug Market Insights Forecast to 2030
Common Drugs Use in Ophthalmology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Choroid Therapy Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Computer Vision in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Dermatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Retinal Disorder Treatment Market Research Report 2024
Diabetic Retinopathy Fundus Image assisted Diagnosis Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Still s Disease Treatment Market Research Report 2025
Scar Removal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Viral Conjunctivitis Pipeline Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rheumatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions